4Through the Skin: Percutaneous Bone Conduction

FWhy pierce the skin at all

Bone-conduction hearing exploits a simple fact: the cochlea can be reached by vibrating the skull, not only by sound travelling down the ear canal. The same hair cells respond, so a person whose outer or middle ear is blocked, malformed, or chronically draining can still hear if the skull is set vibrating. Static headband vibrators have done this for over a century, but pressing a driver against intact skin wastes energy, because the soft tissue acts like a cushion that swallows the higher frequencies.

The percutaneous design removes that cushion. A small titanium implant is screwed into the skull behind the ear, the bone grows into its surface over a few weeks, and a short abutment protrudes through a tidy hole in the skin. The external sound processor snaps onto this abutment, so its vibrations pass straight into solid bone with essentially nothing absorbing them on the way. This direct-drive principle is what makes percutaneous systems the efficiency reference against which every newer bone-conduction device is measured.[2015]

TOsseointegration and the direct-drive advantage

Osseointegration is the structural fusion of living bone to a titanium surface with no intervening fibrous layer. It depends on a few controllable conditions: highly pure titanium with a roughened, oxide-rich surface that osteoblasts colonise; gentle, copiously cooled drilling, because heating bone past roughly 47 degrees C for even a minute kills the cells that should anchor the implant; and a period of undisturbed healing before the processor is loaded. Modern wider fixtures around 4.5 mm diameter integrate faster and more reliably than the older 3.75 mm screws, so loading at six weeks is now common where three months was once standard.

Because the coupling is rigid bone-to-titanium-to-abutment, the percutaneous path loses almost no signal. Transcutaneous designs that send vibration through intact skin sacrifice roughly 10 to 15 dB, concentrated in the high frequencies that matter most for speech clarity. Percutaneous systems avoid that toll entirely, which is why, all else being equal, they tend to give the highest aided thresholds and the best output for a given amount of sensorineural loss.[2015][2005]

CThe systems and their processors

Two manufacturers dominate. Cochlear markets the percutaneous line as Baha Connect, built on the BI300 fixture and a snap-coupling abutment, with sound processors in the Baha range. Oticon Medical offers the Ponto system on its own fixture and abutment, with Ponto processors. The implanted hardware differs only in detail; both rely on the same osseointegration biology and the same snap interface, and processors from either maker apply multichannel compression, directional microphones, and wireless streaming much like a modern air-conduction hearing aid.

Candidacy centres on the bone-conduction thresholds, because that is the curve these devices can reach but rarely beat. Standard percutaneous processors are appropriate when the sensorineural component of a conductive or mixed loss is mild to moderate, broadly up to about 45 to 55 dB HL depending on the processor; beyond that, output runs out. The reversible test is to wear the chosen processor on a softband or test rod first, which approximates the eventual aided result except at the highest frequencies.[2005][2020]

CLiving with an open skin interface

The price of direct drive is a permanent breach in the skin. The abutment must stay clean and the surrounding skin tightly apposed and ideally hairless, so daily hygiene with a soft brush is part of life with the device. Soft-tissue reactions are the commonest complication and are graded with the Holgers scale, from reaction-free skin through redness and granulation to overt infection requiring implant removal. Most reactions are minor and managed with topical care, ointment, or silver nitrate for granulation tissue; skin overgrowth that buries the abutment can be treated by switching to a longer abutment.

Outright loss of the osseointegrated fixture is uncommon in adults, on the order of a few percent, but failure and skin-problem rates rise substantially in young children, where two-stage surgery and softband use until around age five are usual. Compared with magnet-coupled transcutaneous systems, percutaneous devices give better raw hearing but carry higher rates of skin complications and revision care, and the visible abutment is a cosmetic drawback for some patients. The choice between designs is therefore a trade between audiological output and the burden of an open interface.[1988][2020]